Dr Katrina Andrea Bramstedt, PHD | |
203 South Main Street, Sutie 3000, Sheridan, WY 82801 | |
(415) 754-9892 | |
Not Available |
Full Name | Dr Katrina Andrea Bramstedt |
---|---|
Gender | Female |
Speciality | Clinical Ethicist |
Location | 203 South Main Street, Sheridan, Wyoming |
Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1265747471 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
101Y00000X | Counselor | (* (Not Available)) | Secondary |
174H00000X | Health Educator | (* (Not Available)) | Secondary |
174V00000X | Clinical Ethicist | (* (Not Available)) | Primary |
Mailing Address | Practice Location Address |
---|---|
Dr Katrina Andrea Bramstedt, PHD 203 South Main Street, Sutie 3000, Sheridan, WY 82801 Ph: (415) 754-9892 | Dr Katrina Andrea Bramstedt, PHD 203 South Main Street, Sutie 3000, Sheridan, WY 82801 Ph: (415) 754-9892 |
News Archive
Illumina, Inc. today announced that it has delivered Hermann Hauser's genome sequence. Dr. Hauser, Partner, Amadeus Capital Partners Ltd, is the first consumer to purchase Illumina's individual genome sequencing service working with his physician, Michael Nova, MD, of Pathway Genomics.
There has been a lot of information about the importance of taking preventative measures against H1N1, primarily through vaccination. But what if a person has already contracted H1N1? What if that person is a young child?
Flasks, beakers, and hot plates may soon be a thing of the past in medicinal chemistry labs. Instead of handling a few experiments on a benchtop, scientists may simply pop a microchip into a computer and instantly run thousands of chemical reactions, with results literally shrinking the lab down to the size of a thumbnail.
The U.S. Food and Drug Administration today approved Fycompa (perampanel) tablets to treat partial onset seizures in patients with epilepsy ages 12 years and older.
› Verified 7 days ago